Name That Brand: November 2012

Share this article:

Can you name the brand? Each month we print part of a popular pharmaceutical product or advertisement, with clues to its identity. Readers are invited to name the brand for a chance to win a copy of Medicine Avenue II. E-mail your answer to NameThatBrand@haymarketmedia.com or fax 646-638-6150. The deadline is November 30, 2012. The winner will be picked randomly from all correct entries.

Brand X targets many populations
The sign is familiar, but identifying which audience it's meant to resonate with isn't so simple. After all, this brand isn't content with one crowd. This drug is being considered for new indications, which, if approved, could mean shelf space for at least 12 discrete patient populations. The drug maker is so confident that execs brushed off patent expiration worries during a recent earnings call, and said they believe this cornerstone product will continue to wow the marketplace.

SEPTEMBER'S WINNER...
Erin Hicks, product manager at ViiV Healthcare, correctly identified an ad for Takeda's Actos, a prescription medication used to improve blood sugar (glucose) control in adults with type 2 diabetes.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric